← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. NHC
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

NHC logoNational HealthCare Corporation (NHC) P/E Ratio History

Historical price-to-earnings valuation from 1992 to 2025

Current P/E
22.3
Fair Value
5Y Avg P/E
20.9
+7% vs avg
PE Percentile
70%
Above Avg
PEG Ratio
0.97
Attractive
TTM EPS$6.46
Price$171.42
5Y PE Range6.5 - 50.5
Earnings Yield4.47%

Loading P/E history...

NHC Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
22.3vs20.9
+7%
In Line with History
vs. Healthcare
22.3vs22.3
+0%
In Line with Sector
vs. S&P 500
22.3vs25.1
-11%
Below Market
PEG Analysis
0.97
P/E ÷ EPS Growth
PEG < 1 = Attractive
Based on 17% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, National HealthCare Corporation (NHC) trades at a price-to-earnings ratio of 22.3x, with a stock price of $171.42 and trailing twelve-month earnings per share of $6.46.

The current P/E is roughly in line with its 5-year average of 20.9x. Over the past five years, NHC's P/E has ranged from a low of 6.5x to a high of 50.5x, placing the current valuation at the 70th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, NHC is roughly in line with its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

The PEG ratio of 0.97 (P/E divided by 17% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, NHC trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NHC DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

NHC P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
EHC logoEHCEncompass Health Corporation
$11B19.31.36+24%
PNTG logoPNTGThe Pennant Group, Inc.
$1B42.54.23+18%
ADUS logoADUSAddus HomeCare Corporation
$2B18.70.93+23%
SEM logoSEMSelect Medical Holdings Corporation
$2B13.9Lowest--29%
CHE logoCHEChemed Corporation
$6B23.1--7%
HCSG logoHCSGHealthcare Services Group, Inc.
$2B27.5-+53%Best
ENSG logoENSGThe Ensign Group, Inc.
$10B29.82.16+14%
MCK logoMCKMcKesson Corporation
$92B29.20.75Best+15%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

NHC Historical P/E Data (1992–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2025 Q3$121.51$6.4818.8x+19%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$107.01$6.7115.9x+1%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$92.80$6.9213.4x-15%
FY2024 Q4$107.56$6.5416.4x+4%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$125.77$7.9815.8x+0%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$108.40$5.9318.3x+16%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$94.51$5.2618.0x+14%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$92.42$4.3321.3x+36%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$63.98$2.9122.0x+40%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$61.82$2.0729.9x+90%
FY2023 Q1Fri Mar 31 2023 00:00:00 GM$58.07$1.1550.5x+221%
FY2022 Q4Sat Dec 31 2022 00:00:00 GM$59.50$1.3843.1x+174%

Average P/E for displayed period: 15.7x

See NHC's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is NHC Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare NHC vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

NHC — Frequently Asked Questions

Quick answers to the most common questions about buying NHC stock.

Is NHC stock overvalued or undervalued?

NHC trades at 22.3x P/E, near its 5-year average of 20.9x. The 70th percentile ranking places valuation within normal historical bounds.

How does NHC's valuation compare to peers?

National HealthCare Corporation P/E of 22.3x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.

What is NHC's PEG ratio?

NHC PEG ratio is 0.97. Below 1.0 indicates valuation is supported by earnings growth rate. Historical P/E data spans 1992-2025.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

NHC P/E Ratio History (1992–2025)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.